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Abstract: Population-based cancer registries play a key role in cancer monitoring, and their 
utility relies heavily on the completeness and validity of the registered data. It is crucial to 
reduce incomplete stage information and to strengthen the role of TNM stage as key variables 
in the Danish Cancer Registry and other cancer registries. In this respect, distinction in cancer 
registries between evidence that staging was not performed clinically versus truly missing data 
would be an important next step. The present studies examined the completeness of the TNM 
staging data. In future studies it will be important to evaluate the accuracy as well.
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Introduction
Population-based cancer registries play a key role in cancer monitoring. The primary 
objective of the registries is to provide continuously and systematically updated 
information on cancer incidence, prevalence, mortality, and survival of cancer in the 
underlying countries or regions.1,2 However, the applications and use of cancer registry 
data have evolved beyond routine statistics on cancer occurrence and outcome. The 
modern cancer registries provide data to a number of other areas within cancer moni-
toring which, according to the World Health Organization,3 includes:
•	 assessing the current magnitude of the cancer burden and its likely future 
evolution;
•	 providing a basis for research on cancer causes and prevention;
•	 providing information on prevalence and trends in risk factors; and
•	 monitoring the effects of early detection/screening, treatment, and palliative 
care.
Still, the utility of cancer registries and their ability to address these tasks rely 
heavily on the completeness and validity of the registered data.
Cancer registry data: completeness of  TNM staging
The studies reported in the present supplement to Clinical Epidemiology examined the 
completeness and pattern of missing information on TNM stage for selected cancer 
sites recorded in the Danish Cancer Registry (DCR), which is the oldest nationwide 
cancer registry in the world. Cancer stage is a cornerstone in the management of 
cancer and has important uses in cancer monitoring. With a given TNM stage reflect-
ing the severity and spread of cancer at the time of diagnosis, cancer stage is used to 
estimate prognosis, guide selection of primary or adjuvant treatment, and to evaluate 
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treatment results. In addition to this, secondary prevention 
through early detection and treatment is monitored, in part, 
by stage at time of diagnosis with, on average, earlier stage 
diagnoses over time indicating improved performance of the 
health care system.4,5
The DCR records incident cancer cases based on com-
bined information from in- or outpatient hospital settings 
registered in the Danish National Patient Register, primary 
sector practitioners, the Danish Pathology Register, and death 
certificates.6–9 Since 2004, notifications from hospitals and 
primary sector practitioners have been performed electroni-
cally, thereby integrating cancer registration into the patient 
administrative systems.6 Information on cancer staging in 
the DCR has, since 2004, been recorded according to The 
American Joint Committee on Cancer’s TNM classification.6 
The DCR is an important data resource for monitoring and 
research, but analyses of trends in stage-specific incidence 
and mortality are impaired if stage information is missing. 
Thus, it is important to examine the quality of the cancer 
registry data and to evaluate the characteristics of patients 
with unstaged cancer, including how they may differ from 
staged cases.10 This will facilitate evaluation of the magnitude 
and direction of potential biases in studies using information 
on stage.
What can be learned from  
the reports in this supplement?
Overall, the reports demonstrated a substantial variation 
in the completeness of TNM stage registration in the DCR 
according to cancer site, and the proportions of missing stage 
information were generally not trivial. In particular, com-
plete information on stage was not available for two-thirds 
of prostate cancer patients and more than half of bladder 
cancer patients. The studies consistently report the highest 
proportions of unstaged cancer cases in patients of old age 
and/or high level of comorbidity. For example, information 
on TNM stage was available for 75% of patients with prostate 
cancer aged 0–39 years compared to only 11% of those aged 
80 years and older. This indicates a huge disparity of cancer 
care according to age and comorbidity. However, the causes 
of missing stage data are likely multifactorial, including other 
characteristics than age or comorbidity. Besides incomplete 
diagnostic assessment related to age and comorbidity, poten-
tial explanations include:11–13
•	 Apparent signs of distant metastases, obviating the need 
for staging in treatment decisions.
•	 The patient and/or the family have chosen not to pursue 
further investigations.
•	 Incomplete documentation of stage by the physician, 
notably failure to report the final TNM stage after 
completed clinical work-up.
•	 Errors in coding of the retrieved data.
•	 Other potential inconsistencies in the recording 
process.
Potential implications
The findings of these reports have important implications. 
If a large proportion of cancer cases are missing stage 
information, the aspects of cancer monitoring that rely on 
this information will be compromised and thereby limit the 
inferences that can be made, for example, about the effect 
of early detection strategies. The findings also have method-
ological implications. Previous studies have often excluded 
unstaged cancers, categorized them with late-stage cancers, 
or analyzed them in a separate category. However, exclusion 
of patients with missing data not only wastes valuable data, 
but can also lead to invalid results if the excluded group is a 
selected subsample from the source population as indicated 
in basically all reports in this supplement. In addition, it is 
clearly unfortunate to combine unstaged cancer cases into a 
single group, if those patients are in fact distributed across 
all stage categories. Recently, more efficient and less biased 
alternatives to complete case analysis, such as multiple impu-
tation or inverse probability weighting, have been developed 
and included in statistical software packages, thus enabling 
standardized imputation of missing data on stage in cancer 
studies.14,15
What are the next steps?
An important question is whether the findings identify a 
problem with the quality of care being provided to older 
persons. It is difficult to determine this based solely on 
calculations of the proportions of patients with missing data 
on stage. According to the Surveillance, Epidemiology, and 
End Results registers in the United States, unstaged cancer 
is defined as “cancer for which there is not enough informa-
tion to indicate a stage.”16 As noted, this may reflect either 
the absence of clinical work-up to yield this information, or 
the failure of surveillance to capture clinical information that 
does exist. Identifying the reasons for missing staging data 
is warrented. It is likely that the compromised health status 
of some elderly cancer patients results in fewer diagnostic 
procedures and treatment options, which may well be the 
most ethically sound practice. However, there is also growing 
recognition that increasing segments of the older population 
can tolerate and may benefit from cancer treatment.
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It is crucial to reduce incomplete stage information and 
to strengthen the role of TNM stage as key variables in the 
DCR and other cancer registries. In this respect, distinction 
in cancer registries between evidence that staging was not 
performed clinically versus truly missing data would be an 
important next step. The present studies examined the com-
pleteness of the TNM staging data. In future studies it will 
be important to evaluate the accuracy as well.
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